Literature DB >> 18637507

Structure and formation of the cytomegalovirus virion.

W Gibson1.   

Abstract

Transport and protection of the nuclear-replicating double-stranded DNA genome of herpesviruses is accomplished by the virion and its substructures. Studies of the composition, organization, and formation of these particles have provided insight into the molecular mechanisms of virus assembly, leads for antiviral strategies, and information about cellular processes that are required for, resemble, or antagonize virus replication. This chapter updates earlier reviews on the structure and formation human cytomegalovirus (HCMV) virions (Gibson 1996, 2006; Eickmann et al. 2006), and complements several other reviews on herpesvirus structure and replication presented in this volume (see the chapters by E. Murphy and T. Shenk, Z. Ruzsics and U. Koszinowski, R. Kalejta, and G.S. Pari) and elsewhere (Rixon 1993; Steven and Spear 1997; Brown et al. 2002; Varnum et al. 2004; Liu and Zhou 2007).

Entities:  

Mesh:

Year:  2008        PMID: 18637507     DOI: 10.1007/978-3-540-77349-8_11

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  36 in total

1.  Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes.

Authors:  Shinya Omoto; Edward S Mocarski
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

2.  Mutational analysis of the Pseudomonas aeruginosa myovirus KZ morphogenetic protease gp175.

Authors:  Julie A Thomas; Lindsay W Black
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

3.  Unraveling the role of the C-terminal helix turn helix of the coat-binding domain of bacteriophage P22 scaffolding protein.

Authors:  G Pauline Padilla-Meier; Eddie B Gilcrease; Peter R Weigele; Juliana R Cortines; Molly Siegel; Justin C Leavitt; Carolyn M Teschke; Sherwood R Casjens
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

4.  Role of the endoplasmic reticulum chaperone BiP, SUN domain proteins, and dynein in altering nuclear morphology during human cytomegalovirus infection.

Authors:  Nicholas J Buchkovich; Tobi G Maguire; James C Alwine
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

5.  Highly acidic C-terminal region of cytomegalovirus pUL96 determines its functions during virus maturation independently of a direct pp150 interaction.

Authors:  Teal M Brechtel; Edward S Mocarski; Ritesh Tandon
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

6.  Deletion of the human cytomegalovirus US17 gene increases the ratio of genomes per infectious unit and alters regulation of immune and endoplasmic reticulum stress response genes at early and late times after infection.

Authors:  Stephen J Gurczynski; Subhendu Das; Philip E Pellett
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

7.  A targeted spatial-temporal proteomics approach implicates multiple cellular trafficking pathways in human cytomegalovirus virion maturation.

Authors:  Nathaniel J Moorman; Ronit Sharon-Friling; Thomas Shenk; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2009-12-20       Impact factor: 5.911

8.  Human cytomegalovirus tegument protein pUL71 is required for efficient virion egress.

Authors:  Andrew Womack; Thomas Shenk
Journal:  mBio       Date:  2010-11-30       Impact factor: 7.867

9.  Nuclear localization sequences in cytomegalovirus capsid assembly proteins (UL80 proteins) are required for virus production: inactivating NLS1, NLS2, or both affects replication to strikingly different extents.

Authors:  Nang L Nguyen; Amy N Loveland; Wade Gibson
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

10.  Cleavage specificity of the UL48 deubiquitinating protease activity of human cytomegalovirus and the growth of an active-site mutant virus in cultured cells.

Authors:  Eui Tae Kim; Se Eun Oh; Yun-Ok Lee; Wade Gibson; Jin-Hyun Ahn
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.